Stockreport

Sanofi SA (SNY) Q4 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Dupixent Sales: EUR4.2 billion in Q4, EUR15.7 billion annually. Vaccines Sales: EUR7.9 billion for the full year. Business EPS Growth: 26.7% in Q4, 15% for the full [Read more]